FDA Recommends Contraception Device for Sterilization

An FDA advisory panel has recommended the approval of Hologic Inc.'s Adiana female contraception device for permanent sterilization. The device is used as an alternative, minimally invasive method to tubal ligation and can be performed in a doctor's office using local anesthesia.

December 14, 2007

1 Min Read
MDDI logo in a gray background | MDDI

In a 10-3 vote, FDA recommended the approval under certain conditions, including long-term follow up of current pivotal trial patients, more specific labeling, and a new postapproval study of new patients and doctors. The procedure, which takes about 15 minutes, uses radio signals to make a lesion inside the fallopian tube. Once a catheter introduces a soft material (smaller than a grain of rice) into the tube, tissue grows on and around the material to create a permanent blockage. Women can resume their normal activities in one day, versus conventional bilateral tubal ligation, which is performed under general anesthesia and requires a four- to five-day recovery period. The device's pregnancy prevention efficacy rate is 98.9% after one year.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like